Maladies auto-immunes à manifestations cutanées

Rose, 1993, Defining criteria for auto-immune diseases, Immunol Today, 14, 426, 10.1016/0167-5699(93)90244-F Schwarz, 1990, Desmosomes and hemidesmosomes: constitutive molecular components, Ann Rev Cell Biol, 6, 461, 10.1146/annurev.cb.06.110190.002333 Steinman, 1991, The dendritic cell system and its role in immunogenicity, Ann Rev Immunol, 9, 271, 10.1146/annurev.iy.09.040191.001415 Gaspari, 1991, Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified kersatinocytes, J Immunol, 147, 4155, 10.4049/jimmunol.147.12.4155 Stingl, 1993, The epidermis: an immunologic microenvironment, 172 Korman, 1989, Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N, Engl J Med, 321, 631, 10.1056/NEJM198909073211002 Morioka, 1987, Involvement of urokinase type plasminogen activator in acantholysis induced by pemphigus IgG, J Invest Dermatol, 89, 474, 10.1111/1523-1747.ep12460937 Rock, 1990, Monovalent Fab'immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice, J Clin Invest, 85, 296, 10.1172/JCI114426 Anhalt, 1981, Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium, J Clin Invest, 68, 1097, 10.1172/JCI110333 Liu, 1995, The role of complement in experimental bullous pemphigoid, J Clin Invest, 95, 1539, 10.1172/JCI117826 Gammon, 1982, An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes and complement, J Invest Dermatol, 78, 285, 10.1111/1523-1747.ep12507222 Baba, 1976, An eosinophil chemotactic factor present in blister of bullous pemphigoid patients, J Immunol, 116, 112, 10.4049/jimmunol.116.1.112 Briggaman, 1984, Degradation of the epidermal dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leucocytes, J Exp Med, 160, 1027, 10.1084/jem.160.4.1027 Dubertret, 1980, Cellular events leading to blister formation in bullous pemphigoid, Br J Dermatol, 104, 615, 10.1111/j.1365-2133.1980.tb01683.x Claudy, 1991, La pemphigoïde gestationis: un modèle d'auto-immunité spécifique d'organe, Ann Dermatol Venereol, 118, 323 Woodley, 1988, Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen, J Clin Invest, 81, 683, 10.1172/JCI113373 Borradori, 1995, Passive transfer of autoantibodies from a patient with mutilating epidermolyis bullosa acquisita induces specific alterations in the skin of neonatal mice, Arch Dermatol, 131, 590, 10.1001/archderm.1995.01690170092014 Bodvarsson, 1993, Dermatitis Herpetiformis, an autoimmune disease due to crossreaction between dietary glutenin and dermal elastin?, Scand J Immunol, 38, 546, 10.1111/j.1365-3083.1993.tb03239.x Haftek, 1994, Immunogold localization of the 97 Kd antigen of linear IgA bullous dermatosis (LABD) detected with patients's sera. J, Invest Dermatol, 103, 656, 10.1111/1523-1747.ep12398417 Moellmann, 1985, On the subject of serum antibodies to melanocytes in vitiligo, J Invest Dermatol, 84, 333 Hertz, 1972, Autoimmune vitiligo: detection of antibodies to melaninproducing cells, N Engl J Med, 297, 634, 10.1056/NEJM197709222971204 Song, 1994, The role of tyrosinase in autoimmune vitiligo, Lancet, 344, 1049, 10.1016/S0140-6736(94)91709-4 Penning, 1984, Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis, Clin Exp Immunol, 58, 548 Roumm, 1984, Lymphocytes in the skin of patient with progressive systemic sclerosis quantification, subtypes, and clinical correlation, Arthritis Rheum, 27, 645, 10.1002/art.1780270607 Muryoi, 1991, Self reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-topoisomerase autoantibodies, Autoimmunity, 9, 109, 10.3109/08916939109006746 Wallace, 1994, A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice, Eur J Immunol, 24, 1463, 10.1002/eji.1830240634 Walker, 1989, Ketotifen prevents skin fibrosis in the tight skin mouse, J Rheum, 17, 57 Wofsky, 1985, Treatment of murine lupus with monoclonal anti-T cell antibody, J Immunol, 134, 852, 10.4049/jimmunol.134.2.852 Musette, 1994, The expansion of a CD4+ T cell population bearing a distinctive b chain in MRL lpr/Lpr mice suggests a role for the Fas protein in peripheral T cell selection, Eur J Immunol, 24, 2761, 10.1002/eji.1830241128 Musette, 1996, Urtica dioica agglutinin, a Vβ83-specific superantigen, prevents the development of the systemic lupus erythematouslike pathology of MRL lpr/Lpr mice, Eur J Immunol, 26, 1707, 10.1002/eji.1830260807 Lüdemann, 1990, Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme, J Exp Med, 171, 357, 10.1084/jem.171.1.357 Musette, 1991, Wegener's autantigen and leukemia, Blood, 77, 1398, 10.1182/blood.V77.6.1398.1398 Bories, 1989, Down regulation of a serine protease, Myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells, Cell, 59, 959, 10.1016/0092-8674(89)90752-6 Mueller, 1979, Cyclosporine A for psoriasis, N Engl J Med, 301, 555, 10.1056/NEJM197909063011015 Nicolas, 1991, CD4 antibody treatment of severe psoriasis, Lancet, 338, 321, 10.1016/0140-6736(91)90465-2 Gottleib, 1995, Response of psoriasis to a lymphocyte-selective toxin (DAB IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis, Nature Med, 1, 442, 10.1038/nm0595-442 Valdimarsson, 1986, Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes, Immunol Today, 7, 256, 10.1016/0167-5699(86)90005-8 Valdimarsson, 1995, Psoriasis: a T cell mediated autoimmune disease induced by streptococcal superantigens?, Immunol Today, 16, 145, 10.1016/0167-5699(95)80132-4 Chang, 1994, CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ131 genes, 91, 9282 Boehncke, 1995, T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of Superantigen-associated Vβ regions, J Invest Derm, 104, 725, 10.1111/1523-1747.ep12606966 Leung, 1995, Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis, J Clin Invest, 96, 2106, 10.1172/JCI118263 Prinz, 1994, T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products, Eur J Immunol, 24, 593, 10.1002/eji.1830240315 Prens, 1991, The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: A crucial role for epidermal HLA-DR+/CD1a-antigenpresenting cells, J Invest Derm, 96, 880, 10.1111/1523-1747.ep12475275 Lefeber, 1984, Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes, J Clin Invest, 74, 1545, 10.1172/JCI111569 Thomas, 1986, Effect of lupus-inducing drugs of the B to Z transition of synthetic DNA, Arthritis Rheum, 29, 638, 10.1002/art.1780290508 Musette, 1996, Expansion of a recurrent Vβ 5.3+ T cell population in newly diagnosed and untested HLA-DR2 multiple sclerosis patients